REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
A strategy for optimizing erythropoietin therapy in patients with erythropoietin resistance.
A multi-centered, open-label, randomized, controlled trial.